An ambulatory infectious disease clinic evaluates a 45-year-old male patient who recently received a diagnosis of active cavitary pulmonary tuberculosis. His initial sputum acid-fast bacilli (AFB) smear is positive, and rapid molecular testing has confirmed the presence of a pan-susceptible Mycobacterium tuberculosis isolate. As he prepares to commence standard antituberculous pharmacotherapy, the clinical team formulates his longitudinal care plan.
Arrange the following steps representing the appropriate monitoring and treatment evaluation protocol for this patient in the correct chronological sequence.
- 1Perform baseline visual acuity testing and a hepatic function panel before initiating the four-drug intensive regimen.
- 2Transition to a two-drug continuation phase with isoniazid and rifampin upon completing 8 weeks of intensive therapy.
- 3Review the finalized 8-week follow-up sputum culture, which demonstrates persistent growth of Mycobacterium tuberculosis.
- 4Extend the planned two-drug continuation phase from 4 months to 7 months due to delayed microbiologic clearance.
- 5Assess for treatment completion and verify clinical resolution at the conclusion of the 9-month total therapy course.
Answer
The correct chronological sequence is to first perform baseline testing, then transition to a two-drug phase at exactly 8 weeks, subsequently review the finalized 8-week culture, extend the continuation phase based on that delayed result, and finally verify treatment completion at 9 months.
The chronological sequence for monitoring and treating cavitary pulmonary tuberculosis follows a strict protocol. Baseline safety labs and visual acuity testing must be obtained before initiating therapy. At exactly 8 weeks, the intensive phase concludes, and therapy is de-escalated to a two-drug continuation phase (assuming pan-susceptibility). Because mycobacterial cultures take several weeks to grow, the finalized results of the 8-week sputum culture are reviewed after the patient has already entered the continuation phase. Upon discovering that this 8-week culture remains positive in a patient with cavitary disease, treatment evaluation protocols require extending the continuation phase from 4 months to 7 months. Finally, clinical resolution is verified at the end of the newly adjusted 9-month course.
Step-by-Step Solution
Key Concept
The standard monitoring protocol for cavitary pulmonary tuberculosis involves an 8-week intensive phase, transition to a continuation phase, and subsequent retrospective evaluation of 2-month culture results to determine if the treatment duration must be extended from 6 to 9 months.
Estimated Time:1m 30s